Health Campus The Hague, Leiden University Medical Center, The Hague, The Netherlands
Department of Public Health and Primary Care, Leiden University Medical Center, Leiden, The Netherlands.
BMJ Open. 2023 Jun 23;13(6):e071354. doi: 10.1136/bmjopen-2022-071354.
Throughout Europe, many countries offer population-based cancer screening programmes (CSPs). In the Netherlands, two implemented CSPs are targeting people of 50 years and older, aiming at breast cancer (BC) and colorectal cancer (CRC). In order for a CSP to be (cost-)effective, high participation rates and outreach to the populations at risk are essential. People living in highly urbanised areas and big cities are known to participate less in CSPs. The aim of this study was to gain further insight into the participation patterns of a screening-eligible population of 50 years and over, living in a highly urbanised region, over a longer time period.
A retrospective observational study.
Participation data of the regional screening organisation, linked to the cancer incidence data derived from the Netherlands Cancer Registry, concerning the city of The Hague, between 2005 and 2019. Attendance groups were defined as attenders (attending >50% of the invitations) and non-attenders (attending ≤50% of the invitations), and were mutually compared.
The databases contained 106 377 unique individuals on the BC screening programme (SP) and 73 669 on the CRC-SP. Non-attendance at both CSPs was associated with living in a lower socioeconomic status (SES) neighbourhood and as a counter effect, also associated with a more unfavourable, relatively late-stage, tumour diagnosis. When combining the results of the two CSPs, our results imply high screening adherence over time. Women who did not participate in both CSPs were older, and more often lived in neighbourhoods with a lower SES score.
Since low screening uptake is one of the factors that contribute to increasing inequalities in cancer survival, future outreach strategies should be focused on engaging specific non-attending subgroups.
在整个欧洲,许多国家都提供基于人群的癌症筛查计划(CSP)。在荷兰,有两个针对 50 岁及以上人群的 CSP,旨在针对乳腺癌(BC)和结直肠癌(CRC)。为了使 CSP 具有成本效益,必须提高参与率并扩大对高危人群的服务范围。众所周知,生活在高度城市化地区和大城市的人参与 CSP 的比例较低。本研究旨在更深入地了解生活在高度城市化地区、年龄在 50 岁及以上的筛查合格人群在较长时间内的参与模式。
回顾性观察性研究。
2005 年至 2019 年期间,与荷兰癌症登记处的癌症发病率数据相关联的地区筛查组织的参与数据,涉及海牙市。将参加组定义为参加者(参加人数超过邀请人数的 50%)和不参加者(参加人数等于或少于邀请人数的 50%),并进行相互比较。
数据库中包含了 106377 名参加 BC 筛查计划(SP)的个体和 73669 名参加 CRC-SP 的个体。两个 CSP 的不参加均与生活在较低社会经济地位(SES)的社区有关,作为反效果,也与更不利的、相对较晚的肿瘤诊断有关。当将两个 CSP 的结果结合起来时,我们的结果表明随着时间的推移,筛查的依从性很高。没有参加两个 CSP 的女性年龄更大,并且更经常生活在 SES 评分较低的社区。
由于低筛查参与率是导致癌症生存不平等程度增加的因素之一,因此未来的外展策略应侧重于吸引特定的不参加亚组。